Paracentesis Is Associated With Reduced Mortality in Patients Hospitalized With Cirrhosis and Ascites

被引:68
作者
Orman, Eric S. [1 ,3 ]
Hayashi, Paul H. [1 ]
Bataller, Ramon [1 ,2 ]
Barritt, A. Sidney [1 ]
机构
[1] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA
[2] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA
[3] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
Peritonitis; Quality of Health Care; Health Services; NIS Analysis; Liver Fibrosis; SPONTANEOUS BACTERIAL PERITONITIS; CLASSIFICATION-OF-DISEASES; NATURAL-HISTORY; ADMINISTRATIVE DATA; VETERANS-AFFAIRS; VALIDITY; CODES; MANAGEMENT; PERFORM; CARE;
D O I
10.1016/j.cgh.2013.08.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Diagnostic paracentesis is recommended for patients with cirrhosis who are admitted to the hospital for ascites or encephalopathy. However, it is not known whether clinicians in the United States adhere to this recommendation; a relationship between paracentesis and clinical outcome has not been reported. We analyzed a U.S. database to determine the frequency of paracentesis and its association with mortality. METHODS: The 2009 Nationwide Inpatient Sample (which contains data from approximately 8 million hospital discharges each year) was used to identify patients with cirrhosis and ascites who were admitted with a primary diagnosis of ascites or encephalopathy. In-hospital mortality, length of stay, and hospital charges were compared for those who did and did not undergo paracentesis. Outcomes were compared for those who received an early paracentesis (within 1 day of admission) and those who received one later. RESULTS: Of 17,711 eligible admissions, only 61% underwent paracentesis. In-hospital mortality was reduced by 24% among patients who underwent paracentesis (6.5% vs 8.5%; adjusted odds ratio, 0.55; 95% confidence interval, 0.41-0.74). Most paracenteses (66%) occurred <= 1 day after admission. In-hospital mortality was lower among patients who received early paracentesis than those who received it later (5.7% vs 8.1%, P = .049), although this difference was not significant after adjustment for confounders (odds ratio, 1.26; 95% confidence interval, 0.78-2.02). Among patients who underwent paracentesis, the mean hospital stay was 14% longer and hospital charges were 29% greater than for patients who did not receive the procedure. CONCLUSIONS: Paracentesis is underused for patients admitted to the hospital with ascites; the procedure is associated with increased short-term survival. These data support practice guidelines derived from expert opinion. Studies are needed to identify barriers to guideline adherence.
引用
收藏
页码:496 / +
页数:9
相关论文
共 23 条
[1]   Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding [J].
Chavez-Tapia, Norberto C. ;
Barrientos-Gutierrez, Tonatiuh ;
Tellez-Avila, Felix I. ;
Soares-Weiser, Karla ;
Uribe, Misael .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (09)
[2]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231
[3]   Risk of Complications After Abdominal Paracentesis in Cirrhotic Patients: A Prospective Study [J].
De Gottardi, Andrea ;
Thevenot, Thierry ;
Spahr, Laurent ;
Morard, Isabelle ;
Bresson-Hadni, Solange ;
Torres, Ferran ;
Giostra, Emiliano ;
Hadengue, Antoine .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (08) :906-909
[4]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[5]   CEFOTAXIME IS MORE EFFECTIVE THAN IS AMPICILLIN-TOBRAMYCIN IN CIRRHOTICS WITH SEVERE INFECTIONS [J].
FELISART, J ;
RIMOLA, A ;
ARROYO, V ;
PEREZAYUSO, RM ;
QUINTERO, E ;
GINES, P ;
RODES, J .
HEPATOLOGY, 1985, 5 (03) :457-462
[6]   COMPENSATED CIRRHOSIS - NATURAL-HISTORY AND PROGNOSTIC FACTORS [J].
GINES, P ;
QUINTERO, E ;
ARROYO, V ;
TERES, J ;
BRUGUERA, M ;
RIMOLA, A ;
CABALLERIA, J ;
RODES, J ;
ROZMAN, C .
HEPATOLOGY, 1987, 7 (01) :122-128
[7]   EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver [J].
Gines, Pere ;
Angeli, Paolo ;
Lenz, Kurt ;
Moller, Soren ;
Moore, Kevin ;
Moreau, Richard ;
Merkel, Carlo ;
Ring-Larsen, Helmer ;
Bernardi, Mauro .
JOURNAL OF HEPATOLOGY, 2010, 53 (03) :397-417
[8]  
HCUP Nationwide Inpatient Sample (NIS), 2009, HEALTHC COST UT PROJ
[9]   The Quality of Care Provided to Patients With Cirrhosis and Ascites in the Department of Veterans Affairs [J].
Kanwal, Fasiha ;
Kramer, Jennifer R. ;
Buchanan, Paula ;
Asch, Steven M. ;
Assioun, Youssef ;
Bacon, Bruce R. ;
Li, Juan ;
El-Serag, Hashem B. .
GASTROENTEROLOGY, 2012, 143 (01) :70-77
[10]   An Explicit Quality Indicator Set for Measurement of Quality of Care in Patients With Cirrhosis [J].
Kanwal, Fasiha ;
Kramer, Jennifer ;
Asch, Steven M. ;
El-Serag, Hashem ;
Spiegel, Brennan M. R. ;
Edmundowicz, Steven ;
Sanyal, Arun J. ;
Dominitz, Jason A. ;
McQuaid, Kenneth R. ;
Martin, Paul ;
Keeffe, Emmet B. ;
Friedman, Lawrence S. ;
Ho, Samuel B. ;
Durazo, Francisco ;
Bacon, Bruce R. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (08) :709-717